Overview

Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects

Status:
Not yet recruiting
Trial end date:
2023-07-07
Target enrollment:
Participant gender:
Summary
A dose escalating study of PRS-220 administered by oral inhalation in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Pieris Australia Pty Ltd